The ELISA (enzyme-linked immunosorbent assay) is a valuable and adaptable tool for researchers in global biochemistry, molecular biology, and diagnostics. It is a simple and efficient assay for ...
To assess if SARS-CoV-2 (COVID-19) systemic disease can be determined by available nucleoprotein assays, we compared the performance of three commercial SARS-CoV-2 nucleoprotein (N) assays in plasma.
Traditionally, protein biomarkers or analytes have been measured individually in ELISAs, which can attain a high degree of analytical specificity by testing only a single analyte with a dedicated ...
The in-house ELISA SARS-CoV-2 serological assay, developed by the Armauer Hansen Research Institute (AHRI) in Ethiopia, measures anti-SARS-CoV-2 receptor binding domain (RBD) antibodies. This study ...
CAMBRIDGE, England, April 13, 2026 /PRNewswire/ -- Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced SimpleStep Ignite™ ELISA, a next ...
Biological assays drive basic R&D, the identification of new biomarkers, and subsequent diagnostic testing. Two recent conferences highlighted new insights, detailed updates, and showcased novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results